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Abstract
Current approaches in the treatment of obesity include medication, surgery, 
physical activity, diet modifications and overall lifestyle changes. However the 
obesity epidemic still prevails. An understanding of the immunological processes 
that regulate obesity may contribute to better treatment modalities for obesity 
and obesity-related disorders.
Keywords: Obesity; Immunological processes; Regulatory T Cells; Natural 
killer cells
1 and IL-6 present in adipose tissues or in the circulation correlates 
to insulin resistance and metabolic syndrome [5]. In addition, high 
levels of macrophages present in adipose tissues secrete significant 
amounts of pro-inflammatory cytokines, TNF alpha and IL-6 which 
contribute towards insulin resistance. Macrophages also secrete iNOS 
[6]. iNOS, inducible nitric oxide synthase, is involved in immune 
responses responsible for cardiovascular disease. Furthermore, T 
cells, chemokines (such as RANTES) and interferon (IFN)-gamma 
are abundantly found in adipose cells, suggesting a role of T cells in 
obesity (Figure 1). The role of macrophages and T cells in adipose 
tissues remains to be determined, however, depletion of such cells 
may give us greater insights in the understanding and management of 
obesity-associated co-morbidities. Indeed, the long term depletion of 
T cells in mice has been shown to reverse insulin resistance in obesity 
[7], however, whether adipose T cell depletion has similar effects in 
humans is not clear. Further, T helper (Th)-17 cells are associated 
with autoimmune diseases as demonstrated in models for multiple 
sclerosis and colitis. In diet induced obese mice, high levels of IL-
17 are secreted by Th17 cells [8], suggesting an association between 
obesity with inflammatory cells and autoimmune diseases.
Regulatory T cells and Leptin connection 
Regulatory T cells (Treg) are a subpopulation of T cells which 
suppress the activation and proliferation of effector T cells, keeping 
tolerance to self-antigens, abrogating autoimmune cells and 
modulating immune responses. Leptin, a hormone secreted by 
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Introduction
Obesity is a medical condition whereby excess body fat may have 
a negative effect on health. Indeed, the ancient Greeks recognized 
obesity as a medical disorder and Sushruta, the ancient Indian 
surgeon described a link between obesity to heart disease and diabetes 
[1]. During the Middle Ages however, obesity was a sign of prosperity 
and wealth. It wasn’t until the mid-1900s that obesity was scientifically 
associated with various health conditions. Today, obesity is the 6th 
most important risk factor contributing to overall burden of disease 
and is the leading preventable cause of death. Worldwide, 1.2 billion 
adults (1/7) and 10% of children are overweight or obese and in the 
USA alone it accounts to over $190 billion of all medical expenditure. 
Obesity is defined by body mass index and fat distribution as 
measured by waist-hip ratio [2]. Obesity increases the likelihood of 
metabolic syndrome (heart disease, type 2 diabetes, insulin resistance, 
hyperlipidemia), non-alcoholic fatty liver, osteoarthritis, cancer, 
gallbladder disease, autoimmunity, infertility, and obstructive sleep 
apnoea, thus, contributing to decreased life expectancy [3]. In fact, 
obesity contributes to approximately 70% of cases of diabetes [4]. 
Obesity involves a complex pathological process which is reflected 
by environmental and genetic interactions, although a few cases are 
caused primarily by medical disorders (ie, Prader-Willi syndrome, 
Cushings syndrome), medications or psychiatric illness. In addition, 
lifestyle factors such as, inactivity, poor eating habits in particular, 
overconsumption of carbohydrates and lack of sleep are contributing 
factors and appear to be the major factors leading to the current 
obesity epidemic. 
The Immunological Network in Obesity
Chronic inflammation and obesity
Obesity creates an inflammatory state and contributes to the 
development of chronic conditions, including cancer, autoimmunity 
and atherosclerosis. High levels of tumor necrosis factor (TNF) 
alpha, monocyte chemo attractant protein (MCP-1), interleukin (IL)-
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Figure 1: Adipose tissue in obesity. A complex immunological network.
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fat cells reflects the amount of fat stored in the body. In addition, 
Treg cells also secrete leptin which acts as a negative signal for the 
proliferation of Treg cells [9]. In obese patients, high leptin, high 
C-reactive protein levels or high HbA1c levels in the circulation 
correlates with reduced circulatory Treg cells [10]. Reduced Treg cells 
have implications in the development of a number of chronic diseases, 
including cardiovascular diseases and metabolic complications.
Macrophages and dendritic cells in adipose tissues
Adipose tissues consist of Treg cells and eosinophils which 
balance local inflammation and influx of M1 macrophages, T cells 
and B cells. Adipose tissues contain resident macrophages and in 
obesity they are greatly enhanced where they secrete cytokines leading 
to inflammation and insulin resistance. It is believed that adipocyte 
death leads to the recruitment of pro-inflammatory M1 macrophages, 
however, M2 macrophages surround adipocytes and accumulate in 
the absence of adipocyte death (Figure 1). In recent studies, it was 
surprising to note that MHC class II was markedly increased in 
adipocytes of obese subjects [11]. Similarly, in mouse adipocytes, 
MHC class II was enhanced within 2 weeks of a high fat diet, and were 
able to stimulate CD4+ T cells in vitro [11]. Interestingly, MHC class 
II deficiency decreased adipose inflammation and insulin resistance in 
high fat diet mice compared to wild-type mice, despite having similar 
adiposity. Hence, the expression of MHC class II on adipocytes plays 
a role in adaptive immunity in obesity and its down-regulation may 
aid in therapeutic approaches against obesity.
Dendritic cells are present in adipose tissue in obese mice in an 
immature phenotype with lower levels of expression of CD40, CD80, 
CD86, MHC class I and II. However, high levels of IL-6, tumor growth 
factor (TGF)-beta and IL-23 cytokines are secreted and dendritic 
cells stimulate the generation of Th17 cells [12]. Hence dendritic cells 
contribute to the pro-inflammatory state in obesity.
What do eosinophils and mast cells do in adipose tissue?
Eosinophils are granulocytic leukocytes found in peripheral 
blood and tissues and are usually associated with inflammatory 
states, helminth immunity and allergies. They are also present in 
adipose tissues, where they primarily secrete IL-4 and in their absence 
macrophages are significantly enhanced (Figure 1). In the absence of 
eosinophils, high fat diet mice, increase body fat composition and body 
weight develop impaired glucose tolerance and insulin resistance [13]. 
Hence, eosinophils play a role in regulating macrophage activation in 
adipose tissue and aid in keeping the inflammatory balance.
Mast cells are known for their role in anaphylaxis and allergic 
responses. However, mast cells also play a significant role in tumor 
tissues, atherosclerotic lesions and are abundantly present in adipose 
tissues [14]. Mast cells, mature and differentiate in adipose tissues 
and interact with adipocytes to recruit inflammatory cells [15]. In 
obese mice and humans, the plasma mast cell protease levels and 
mast cells in visceral fat are significantly higher compared to lean 
counterparts [16]. In addition, mast cells interact with CD8+T cells 
in adipose tissues and secrete TNF-alpha, IL-8 and oncostatin M 
[17]. Furthermore, mast cells in adipose tissues interact with CD4+T 
cells, Treg cells and dendritic cells [18]. Detailed studies are required 
to understand the role of mast cells in adipose tissues in obesity, 
however, it appears that in obesity they are highly activated, and 
their de-activation could lead to improvements of weight in obese 
individuals. In fact, obese mice lose weight as a result of mast cell 
inactivation [18].
Are there immune cells that protect against obesity?
Natural killer T (NKT) cells share properties of natural killer cells 
and T cells. NKT cells bind to CD1d molecules, expressed on antigen 
presenting cells that presents lipids and glycolipids in complex with 
CD1d. Invariant NKT (iNKT) cells, a subset of NKT cells are innate T 
cells that influence inflammatory responses. iNKT cells were believed 
to be rare in humans, however, emerging evidence suggests they are 
present in adipose tissues and are up-regulated in obesity (Figure 1). 
Depletion of iNKT cells results in infiltration of pro-inflammatory 
macrophages and iNKT cells were restored following weight loss. 
Of relevance, mice lacking iNKT cells have enhanced weight gain, 
larger adipocytes and fatty livers and are insulin resistant. In adoptive 
transfer experiments, iNKT cells were associated with decreased 
body fat, triglycerides, leptin levels, fatty liver and improved insulin 
sensitivity [19]. The mechanism is believed to be via anti-inflammatory 
cytokine production by iNKT cells. Hence, iNKT cells could be used 
in the management of obesity.
Obesity and immune dysfunction: increased risks of 
disease outcomes
There is a link between obesity, metabolic diseases and immune 
dysfunction. Macrophages, lymphocytes and mast cells play a key role 
in initiating an inflammatory milieu in obese patients which leads to 
insulin resistance. Thus, it is not the mass of adipose tissue that leads 
to insulin resistance but the inflammatory state within the adipose 
tissue and systemically that leads to insulin resistance. Dysfunctional 
adipose tissue also leads to other metabolic disorders such as 
dyslipidemia and non-alcoholic steatohepatitis. Hence, adipose tissue 
is not merely a site for fat storage but a complex endocrine organ.
In obese humans, the total number of lymphocytes and NK cells 
are decreased and mitogen stimulation of lymphocytes is reduced 
[20]. Similar findings have been noted in mice [21]. As a result, obesity 
inhibits the ability of the immune system to appropriately respond 
to influenza virus infection in mice, suggesting increased mortality 
from viral infections [22]. In addition, obesity is associated with 
increased risks of urinary tract infections, pneumonia, periodontitis, 
pancreatitis, skin infections, cellulitis and influenza infections 
[reviewed in 23]. Furthermore, obese individuals respond weaker to 
vaccinations, such as hepatitis B vaccine compared to lean individuals. 
In a randomized trial of the triple antigen vaccine resulted in lower 
protection rates in obese vs lean subjects [23].
It is clear that obesity causes immune dysfunction with a chronic 
low grade inflammatory response. As a consequence, a number of 
diseases result, there is an inability to clear infections adequately 
and there are inadequate responses to vaccination. It is known that 
exercise and diet modifications have beneficial effects on the immune 
function. In fact, diet and moderate daily exercise has been shown to 
restore immune function in obesity [24].
Conclusion
With the obesity epidemic expanding at an alarming rate and 
the need to develop effective treatments, it is imperative to take a 
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few steps back to understand the molecular basis and functional role 
of immune cells in obese individuals. Immune cells hold the key to 
developing improved treatments against obesity.
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